GeminIQ Website Logo

Viewing SLS free

Subscribe for full history, 90+ metrics, screener, watchlist...

SELLAS Life Sciences Group, Inc.

SLS

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
13810772442528142191834
Restricted Cash And Cash Equivalents At Carrying V…
000000000000
Prepaid Expense And Other Assets Current
443543233311
Assets Current
143111754929321624122235
Operating Lease Right Of Use Asset
111111111111
Goodwill
222222222222
Deposits Assets Noncurrent
000000000000
Assets
145114785232351927152468
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
343234456764
Accrued Liabilities Current
424323555787
Operating Lease Liability Current
111111111000
Liabilities Current
867667101112141412
Operating Lease Liability Noncurrent
000000000000
Liabilities
877667101112151412
Stockholders Equity
Preferred Stock Value
-------00000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
431391346313287282258257237236209205
Retained Earnings Accumulated Deficit
-293-283-275-267-261-254-248-241-234-227-217-209
Stockholders Equity
13810771462628916310-8-4
Liabilities And Stockholders Equity
145114785232351927152468
Series A Preferred Stock
-------0000-
Preferred Stock Par Or Stated Value Per Share
-------00000
Preferred Stock Shares Authorized
-------55555
Preferred Stock Shares Issued
-------00000
Preferred Stock Shares Outstanding
-------00000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
350350350350350350350350350350350350
Common Stock Shares Issued
20218115312510091746458563228
Shares Outstanding
20218115312510091746458563228

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202657.66%186.97%91.76%---------
202514.18%53.90%17.73%18.63%16.15%13.04%16.78%191.95%153.02%-8.46%-3.65%58.27%
20245.84%-11.68%-12.41%0.00%5.88%0.00%-10.24%-14.96%27.56%-6.61%28.93%33.06%
2023------18.68%16.48%-43.96%52.48%44.55%48.51%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
18.83
17.22
10.72
8.28
4.91
4.64
1.72
2.26
1.02
1.49
0.23
0.44
Quick Ratio
18.29
16.60
10.25
7.50
4.23
4.14
1.47
1.99
0.77
1.28
0.19
0.35
Working Capital
134.94M
104.71M
68.19M
43.13M
23.45M
25.09M
6.82M
13.42M
257.00K
7.06M
-10.56M
-6.53M
Leverage & Debt
Debt to Equity
0.06
0.06
0.11
0.13
0.24
0.26
1.05
0.67
4.19
1.52
-1.78
-3.11
Interest Coverage TTM
-12.77
-15.68
-20.04
-27.07
-29.42
-34.78
-49.86
-48.62
-63.63
-59.99
-53.56
-60.96
Debt Ratio
0.05
0.06
0.10
0.11
0.19
0.21
0.51
0.40
0.81
0.60
2.28
1.47
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-0.17
-0.17
-0.25
-0.24
-0.27
-0.31
-0.50
-0.47
-0.60
-0.80
-1.34
-1.35
Free Cash Flow Per Share TTM
-0.15
-0.16
-0.26
-0.28
-0.32
-0.38
-0.58
-0.48
-0.56
-0.67
-1.13
-1.12
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Revenue Growth (1Y)
-
-
-
-
-
-
-
-
-
-
-100.00%
-100.00%
Net Income Growth (1Y)
23.62%
8.59%
-13.01%
-19.63%
-23.75%
-24.24%
-17.30%
-15.77%
-4.55%
0.43%
-9.59%
-1.17%
EPS Growth (1Y)
-35.60%
-44.75%
-51.18%
-49.40%
-55.42%
-61.32%
-62.47%
-65.01%
-53.05%
-47.23%
-36.87%
-28.33%
Valuation Metrics
P/E TTM
-86.02
-24.77
-15.30
-6.73
-8.22
-3.49
-2.06
-2.64
-1.99
-1.26
-0.79
-1.21
P/B TTM
20.28
6.79
5.80
3.82
8.25
3.41
6.72
5.37
23.54
4.67
-3.69
-12.15
Market Cap
2.79B
729.60M
411.12M
174.52M
215.84M
94.78M
63.65M
85.32M
68.58M
45.26M
29.44M
46.50M
Enterprise Value
2.65B
622.40M
339.23M
130.10M
190.45M
66.28M
49.66M
64.19M
59.33M
26.75M
26.81M
42.43M
Calculated Values
Free Cash Flow TTM
-28.42M
-28.17M
-28.39M
-30.62M
-31.36M
-33.71M
-35.40M
-33.07M
-32.16M
-30.04M
-31.41M
-31.74M
Net Debt
-138.44M
-107.20M
-71.89M
-44.42M
-25.40M
-28.50M
-13.99M
-21.13M
-9.25M
-18.52M
-2.63M
-4.07M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-11-19Purchase
Owner: Kalin, Katherine Bach
Title: -
Shares: 63,400
Price/Share: $1.59
Value: $100,806.00
Shares Owned: 104,400
Relationship: Director
Ownership: Direct
2025-06-12Purchase
Owner: Van, Nostrand Robert L
Title: -
Shares: 10,000
Price/Share: $1.48
Value: $14,800.00
Shares Owned: 20,400
Relationship: Director
Ownership: Direct
2025-05-30Purchase
Owner: Wasman, Jane
Title: -
Shares: 20,000
Price/Share: $1.69
Value: $33,800.00
Shares Owned: 30,400
Relationship: Director
Ownership: Direct
2025-05-22Purchase
Owner: Kalin, Katherine Bach
Title: -
Shares: 20,000
Price/Share: $1.80
Value: $36,000.00
Shares Owned: 41,000
Relationship: Director
Ownership: Direct
2022-12-05Sale
Owner: Wood, Barbara A
Title: EVP, Gen. Counsel, Corp. Sec.
Shares: 2,153
Price/Share: $2.59
Value: $5,576.27
Shares Owned: 56,344
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
30.72%
Inst. Shares: 52,977,817
Shares Outstanding: 172,481,541
2025-12-31
31.68%
Inst. Shares: 34,548,143
Shares Outstanding: 109,051,215
2025-09-30
29.51%
Inst. Shares: 31,983,848
Shares Outstanding: 108,396,260
2025-06-30
26.16%
Inst. Shares: 25,785,922
Shares Outstanding: 98,558,567
2025-03-31
15.90%
Inst. Shares: 13,953,192
Shares Outstanding: 87,760,320

SELLAS Life Sciences Group, Inc. (SLS) — SEC Financial Statements & Analysis

SELLAS Life Sciences Group, Inc. (SLS) is a pharmaceutical preparations company, incorporated in DE. SELLAS Life Sciences Group, Inc. trades on Nasdaq as: SLS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SELLAS Life Sciences Group, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.06x, a Price-to-Book (P/B) ratio of 20.28x (TTM), at a market cap of $2.79B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-100.00%
Debt To Equity
0.06x
P/B TTM
20.28x
Market Cap
$2.79B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SELLAS Life Sciences Group, Inc. in?

SELLAS Life Sciences Group, Inc. (SLS) operates in the Pharmaceutical Preparations industry.

What is SLS's market cap?

SELLAS Life Sciences Group, Inc. (SLS) has a market capitalization of $2.79B as of 2026-06-30.

What exchange does SLS trade on?

SELLAS Life Sciences Group, Inc. (SLS) trades on the Nasdaq.

Where is SELLAS Life Sciences Group, Inc. incorporated?

SELLAS Life Sciences Group, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.